Generics - Teva Pharmaceutical Industries, Cardio-vascular


Popular Filters

US Appeals Court reverses 2012 decision on Lovaza, clearing way for generics


Reversing a district court decision last year (The Pharma Letter May 30, 2012), the US Court of Appeals…

AmarinCardio-vascularGenericsGlaxoSmithKlineLegalLovazaNorth AmericaPar PharmaceuticalsPatentsPharmaceuticalTeva Pharmaceutical IndustriesVascepa

Teva launches generic Aprovel in UK


The UK subsidiary of Israel's Teva Pharmaceutical Industries (NYSE: TEVA), the world's largest generic…

AprovelBristol-Myers SquibbCardio-vascularEuropeGenericsMarkets & MarketingSanofiTeva Pharmaceutical Industries

EU Commission focus now on Servier and others re-perindopril antitrust issues


The European Commission has informed French independent pharmaceutical company Servier and several of…

Cardio-vascularEuropeGenericsLegalMarkets & MarketingMylan LaboratoriesPatentsperindoprilPharmaceuticalServierTeva Pharmaceutical Industries

USA FDA approves ANDAs for Plan B One-Step and Trandate


Watson Pharmaceuticals (NYSE: WPI) says its subsidiary Watson Laboratories approval from the US Food…

Cardio-vascularGenericsNorth AmericaPar PharmaceuticalsPlan B One-StepRegulationReproductiveTeva Pharmaceutical IndustriesTrandateWatson Pharmaceuticals

Teva debuts generic of Provigil, Avapro and Avalide; Ranbaxy Crestor copy OKed in Canada


Israeli generics giant Teva Pharmaceutical Industries (Nasdaq: TEVA) last Friday launched an authorized…

AstraZenecaAvalideAvaproCardio-vascularCephalonCrestorDaiichi SankyoGenericsMarkets & MarketingNeurologicalNorth AmericaProvigilRanbaxy LaboratoriesRegulationSanofiTeva Pharmaceutical Industries

Forest files suit over Bystolic patent; generic Lexapro launched in USA


US drugmaker Forest Laboratories (NYSE: FRX) and Janssen Pharmaceutica, a unit of health care giant Johnson…

BystolicCardio-vascularForest LaboratoriesGenericsJanssen PharmaceuticaJohnson & JohnsonLexaproNeurologicalNorth AmericaPatentsRegulationTeva Pharmaceutical IndustriesWatson Pharmaceuticals

Back to top